VRTX Jun 2024 240.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:49AM EST. Market open.
| Previous close | 1.4500 |
| Open | 1.4500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 240.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.4500 - 1.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireVertex Appoints Nancy Thornberry to its Board of Directors
BOSTON, December 05, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Nancy Thornberry has been appointed to its Board of Directors as an independent director. Ms. Thornberry has more than 35 years of experience in the pharmaceutical and biotech industries, spanning drug discovery, development and commercialization. She founded and served as Chief Executive Officer of Kallyope until 2021 and remains on its Board of Directors and is Chair of Research & Development. Pr
ZacksGSK vs. VRTX: Which Stock Should Value Investors Buy Now?
GSK vs. VRTX: Which Stock Is the Better Value Option?
Motley FoolYou Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
© 2023 Yahoo. All rights reserved.